UCM710
Product Specifications
UNSPSC Description
UCM710 is an endocannabinoid (eCB) hydrolysis inhibitor that increases the levels of N-arachidonoyl ethanolamine and 2-arachidonoylglycerol in neurons. UCM710 inhibits fatty acid amide hydrolase and α/β-hydrolase domain 6, but not monoacylglycerol lipase[1].
Target Antigen
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/ucm710.html
Solubility
10 mM in DMSO
Smiles
CCCCCC/C=C\CCCCCCCC(OCC1OC1)=O
Molecular Weight
310.47
References & Citations
[1]Marrs WR, et al. Dual inhibition of alpha/beta-hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons. J Biol Chem. 2011 Aug 19;286(33):28723-28728.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-120300/UCM710-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-120300/
Clinical Information
No Development Reported
CAS Number
213738-77-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E45H50726M2-100 100 ug
SIRP alpha Protein, Human, Recombinant (ECD, SIRP alphaV2, His Tag)
Ask
View Details 